securities fraud

Snowflake faces class action lawsuit alleging failure to disclose material consumption challenges known to executives from June 2023-February 2024, triggering 18% stock decline.

$ODD faces securities fraud lawsuit over undisclosed algorithm changes that increased customer acquisition costs. Lead plaintiff deadline: May 11, 2026.

Vital Farms faces class action lawsuit over alleged ERP system misstatements that caused missed earnings targets between May 2025 and February 2026.

Trip.com investors alleging false regulatory disclosures can pursue class action. Stock dropped 19% after China antitrust investigation revelation.

Class action lawsuit filed against Vital Farms for allegedly concealing ERP system delays that caused the company to miss 2025 earnings guidance, affecting investors from May 2025 through February 2026.

Super Micro Computer faces securities lawsuit over alleged $2.5B export control breach to China. Stock fell 33.3%; lead plaintiff deadline May 26, 2026.

Class action lawsuit filed against $SLNO alleging fraud over PWS drug DCCR. Safety concerns, patient death, and commercial disruption emerged in 2025.

Class action lawsuit filed against $ALIT over alleged false statements about growth prospects and undisclosed sales shortfalls. Stock declined sharply after disappointing earnings.

Class action filed against $CHOW alleging securities fraud, false statements, and undisclosed market-manipulation scheme involving social media misinformation and fraudulent trading.

Class action filed against $INO alleging executives made false statements about CELLECTRA device manufacturing and INO-3107 regulatory timeline between October 2023 and December 2025.

Class action lawsuit filed against $PMI alleging securities fraud, insider share dumping via offshore accounts, and omitted risk disclosures from September-October 2025.

REGENXBIO faces class action securities fraud lawsuit over allegedly concealed safety data for gene therapy RGX-111, triggered by CNS tumor discovery in clinical trial.

Schall Law Firm seeks Franklin BSP Realty Trust ($FBRT) investors for securities fraud lawsuit, alleging false dividend sustainability claims caused investor losses.

DJS Law Group sues $FBRT for allegedly making false statements about dividend sustainability. Class period spans November 2024 to February 2026.

REGENXBIO ($RGNX) sued for alleged securities violations involving undisclosed adverse trial data on RGX-111 candidate after FDA clinical hold.

Schall Law Firm seeks $RGNX investors for securities fraud class action alleging false statements about RGX-111 candidate, following tumor discovery in trial participant.

Schall Law Firm seeks lead plaintiffs in class action against $QURE for alleged false statements regarding FDA approval timeline and BLA submission misrepresentations.

Paysafe faces securities fraud lawsuit alleging false risk disclosures and understated credit reserves. Law firm seeks lead plaintiffs from investors during March-November 2025 period.

Portnoy Law Firm investigates $CCOI for possible securities fraud after JPMorgan, RBC seized $82M in CEO-pledged shares, citing board fiduciary duty breaches.

Wolf Haldenstein filed a securities fraud class action against $GEMI following a 78.7% stock decline from its $28 IPO price, citing undisclosed operational problems and executive departures.